We are live on ! Find out more
GFM

GF Fund Management Portfolio holdings

AUM $5.98B
1-Year Est. Return 80.99%
This Fund
S&P 500
This Quarter Est. Return
+11.47%
1 Year Est. Return
+80.99%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.98B
AUM Growth
+$132M
Cap. Flow
+$20.2M
Cap. Flow %
0.34%
Top 10 Hldgs %
41.51%
Holding
666
New
23
Increased
324
Reduced
223
Closed
42

Top Buys

Rank Stock Value
1
WMT icon
Walmart Inc
WMT
+$142M
2
ASML icon
ASML
ASML
+$117M
3
TSEM icon
Tower Semiconductor
TSEM
+$112M
4
LRCX icon
Lam Research
LRCX
+$88M
5
MU icon
Micron Technology
MU
+$53.9M

Top Sells

Rank Stock Value
1
SNDK
Sandisk
SNDK
+$81.3M
2
LITE icon
Lumentum
LITE
+$72.3M
3
PM icon
Philip Morris
PM
+$40M
4
MSFT icon
Microsoft
MSFT
+$28.5M
5
META icon
Meta Platforms (Facebook)
META
+$27.2M

Sector Composition

Rank Sector Weight
1 Technology 54.47%
2 Communication Services 12.44%
3 Consumer Discretionary 11.77%
4 Consumer Staples 6.03%
5 Healthcare 5.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMRX icon
351
Amneal Pharmaceuticals
AMRX
$5.78B
$87.8K ﹤0.01%
7,060
+882
+14% +$11.8K
LPX icon
352
Louisiana-Pacific
LPX
$4.98B
$87.3K ﹤0.01%
+1,200
New +$101K
CNTA
353
DELISTED
Centessa Pharmaceuticals
CNTA
$86K ﹤0.01%
2,166
+271
+14% +$6.93K
HR icon
354
Healthcare Realty
HR
$7.36B
$85.8K ﹤0.01%
5,049
-485
-9% -$8.51K
INDV icon
355
Indivior Pharmaceuticals
INDV
$4.62B
$85.5K ﹤0.01%
2,804
+351
+14% +$11.6K
ACAD icon
356
Acadia Pharmaceuticals
ACAD
$4.35B
$84.6K ﹤0.01%
3,799
+475
+14% +$11.4K
RHP icon
357
Ryman Hospitality Properties
RHP
$8.2B
$83.6K ﹤0.01%
906
-86
-9% -$8.25K
KRG icon
358
Kite Realty
KRG
$6.03B
$81.6K ﹤0.01%
3,323
-320
-9% -$7.88K
NAMS icon
359
NewAmsterdam Pharma
NAMS
$3.47B
$81.5K ﹤0.01%
2,546
+318
+14% +$10.4K
BRK.B icon
360
Berkshire Hathaway Class B
BRK.B
$1.06T
$80.5K ﹤0.01%
168
-9,876
-98% -$4.85M
CRNX icon
361
Crinetics Pharmaceuticals
CRNX
$8.88B
$77.4K ﹤0.01%
2,131
+267
+14% +$11.9K
DLTR icon
362
Dollar Tree
DLTR
$24.3B
$76.7K ﹤0.01%
700
– –
EWTX icon
363
Edgewise Therapeutics
EWTX
$4.26B
$74.9K ﹤0.01%
2,378
+299
+14% +$8.62K
GPCR icon
364
Structure Therapeutics
GPCR
$3.34B
$72.3K ﹤0.01%
1,500
+188
+14% +$12.9K
MAC icon
365
Macerich
MAC
$7.26B
$72.2K ﹤0.01%
3,820
-368
-9% -$6.97K
MRSH
366
Marsh
MRSH
$87.7B
$72K ﹤0.01%
415
– –
PECO icon
367
Phillips Edison & Co
PECO
$5.51B
$71.1K ﹤0.01%
1,900
-181
-9% -$6.73K
SBRA icon
368
Sabra Healthcare REIT
SBRA
$5.04B
$69.7K ﹤0.01%
3,624
-349
-9% -$6.87K
TARS icon
369
Tarsus Pharmaceuticals
TARS
$2.45B
$66.9K ﹤0.01%
953
+120
+14% +$8.38K
SUPN icon
370
Supernus Pharmaceuticals
SUPN
$2.75B
$66.6K ﹤0.01%
1,288
+162
+14% +$8.25K
IDYA icon
371
IDEAYA Biosciences
IDYA
$3.41B
$65.6K ﹤0.01%
1,969
+247
+14% +$8.29K
TWST icon
372
Twist Bioscience
TWST
$5.45B
$65.2K ﹤0.01%
1,373
+172
+14% +$7.71K
RIO icon
373
Rio Tinto
RIO
$147B
$64.9K ﹤0.01%
696
+693
+23,100% +$63.2K
ARQT icon
374
Arcutis Biotherapeutics
ARQT
$3.44B
$64.8K ﹤0.01%
2,751
+345
+14% +$8.8K
VNO icon
375
Vornado Realty Trust
VNO
$7.48B
$64.1K ﹤0.01%
2,468
-237
-9% -$7.02K
13 14
15
16 17

Similar funds

CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
BP
BC Partners New York $5.96B AUM 15.21% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
CAG
Crestwood Advisors Group Boston, Massachusetts $5.94B AUM 18.44% 1-Year Est. Return
WHRC
W.H. Reaves & Co Jersey City, New Jersey $6.03B AUM 40.55% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
AL
Appaloosa LP Short Hills, New Jersey $5.93B AUM 44.55% 1-Year Est. Return
CGPCS
Capital Group Private Client Services Los Angeles, California $5.93B AUM 27.73% 1-Year Est. Return

GF Fund Management's Q1 2026 Portfolio in Review

As of Q1 2026, GF Fund Management held 666 positions worth $5.98B, up 2.3% from $5.85B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

GF Fund Management's Q1 2026 filing shows 23 new, 324 increased, 223 reduced and 42 closed positions. Its largest new stake was Coherent: 98,000 shares worth $23.3M. The largest sale was Sandisk, an estimated $81.3M.

By sector, the portfolio is most concentrated in Technology at 54% of assets, up from 51% a quarter earlier, followed by Communication Services and Consumer Discretionary.

  • GF Fund Management's largest Q1 2026 buy was Coherent: 98,000 shares worth $23.3M.
  • GF Fund Management added most to Walmart Inc in Q1 2026, an estimated $142M increase.
  • GF Fund Management's biggest Q1 2026 reduction was Sandisk, cutting an estimated $81.3M.
  • GF Fund Management fully exited AstraZeneca in Q1 2026, selling an estimated $12.4M.
  • GF Fund Management's ten largest holdings make up 42% of its $5.98B portfolio in Q1 2026.
  • GF Fund Management opened 23 new positions and closed 42 in Q1 2026.
  • GF Fund Management's portfolio value rose 2.3% quarter-over-quarter to $5.98B.

Based on GF Fund Management's 13F filing for Q1 2026, filed 15 Apr 2026.